PUBLISHER: The Business Research Company | PRODUCT CODE: 1942718
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942718
A digestible sensor is a small, ingestible electronic device designed to be swallowed to monitor internal health conditions or provide specific diagnostic information. These sensors are often embedded in pills and can measure physiological parameters such as temperature, pH, or medication adherence while passing through the gastrointestinal (GI) tract.
The primary types of digestible sensors include capsule sensors, wearable sensors, ingestible sensors, and implantable sensors. Capsule sensors are miniaturized, ingestible devices shaped like a capsule that travel through the GI tract. These devices are distributed through channels such as online retail, pharmacies, hospitals and clinics, and direct sales. They utilize technologies including microelectromechanical systems (MEMS), wireless communication, optical sensors, and bioelectronic interfaces, and are applied in medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, serving end users such as healthcare providers, research institutions, pharmaceutical companies, and individual consumers.
Tariffs are impacting the digestible sensor market by increasing costs for imported microelectromechanical systems (MEMS), bioelectronic interfaces, and wireless components. Segments such as capsule sensors and ingestible sensors are most impacted, with regions like China and India facing higher import duties. These tariffs have led to supply chain challenges and higher product costs, but also promote local manufacturing, innovation in sensor design, and development of cost-effective domestic solutions.
The digestible sensor market research report is one of a series of new reports from The Business Research Company that provides digestible sensor market statistics, including digestible sensor industry global market size, regional shares, competitors with a digestible sensor market share, detailed digestible sensor market segments, market trends and opportunities, and any further data you may need to thrive in the digestible sensor industry. This digestible sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The digestible sensor market size has grown rapidly in recent years. It will grow from $1.37 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to limited availability of ingestible sensor technologies, reliance on conventional diagnostics methods, growing awareness of gi health, early adoption of capsule endoscopy, increasing r&d in bioelectronic interfaces.
The digestible sensor market size is expected to see rapid growth in the next few years. It will grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to advancements in wireless communication and mems technologies, integration with digital health platforms, expansion of personalized medicine initiatives, rising demand for real-time patient monitoring, growth in home healthcare and telemedicine. Major trends in the forecast period include increasing adoption of ingestible sensors for gi health monitoring, integration of sensors with drug adherence programs, expansion of smart capsule endoscopy applications, rising use of electrochemical and gas sensing technologies, growth in personalized patient monitoring solutions.
The growing demand for remote health monitoring is expected to drive the growth of the digestible sensor market in the coming years. Remote health monitoring involves the use of technology to track and manage a patient's health outside conventional healthcare environments, typically at a distance. The increase in remote health monitoring is driven by patient preferences for personalized, real-time healthcare delivered from home, as well as the availability of cost-effective alternatives to traditional in-person consultations. Digestible sensors support remote health monitoring by enabling real-time measurement of internal health parameters, such as gastrointestinal activity, and by providing clinicians with valuable insights into a patient's digestive health, allowing early identification of conditions such as infections or disease without the need for invasive procedures. For example, in August 2025, according to the Office of Inspector General, U.S. Department of Health & Human Services (OIG), Medicare expenditures for remote patient monitoring surpassed US$536 million in 2024, reflecting a 31% increase from 2023, nearly 1 million beneficiaries received RPM services, representing a 27% rise year over year, and approximately 4,600 medical practices regularly billed for RPM services. Therefore, the increasing demand for remote health monitoring is fueling the growth of the digestible sensor market.
The expanding demand for personalized medicine is expected to propel the growth of the digestible sensor market going forward. Personalized medicine is a healthcare approach that leverages information about an individual's genetic makeup, lifestyle, and environment to customize medical treatments and care. The rise of personalized medicine is driven by growing consumer preference for health technologies that provide real-time monitoring and treatment strategies tailored to individual biological profiles. Digestible sensors facilitate personalized medicine by enabling physicians to gather real-time physiological data from within the body, supporting more precise diagnoses and individualized treatment plans based on each patient's unique responses. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the U.S. Food and Drug Administration approved 16 new personalized therapies for rare disease patients in 2023, compared with six in 2022. Overall, the report documented 26 new personalized treatment approvals, 19 expanded indications for existing personalized medicines, and 17 major new or expanded indications for 12 diagnostic testing products. Therefore, the growing demand for personalized medicine is driving the growth of the digestible sensor market.
Major companies in the market are developing miniaturized, multi-parameter ingestible sensors to improve gut health monitoring and diagnostic accuracy. Multi-parameter sensors simultaneously measure multiple physical or chemical parameters in a compact device. For instance, in May 2025, the Interuniversity Microelectronics Centre in Belgium unveiled a highly miniaturized ingestible sensor measuring 2.1 cm in length and 0.75 cm in diameter about three times smaller than traditional endoscopic capsules. The capsule integrates sensors for oxidation-reduction potential (ORP), pH, and temperature, recording readings every 20 seconds throughout digestion. Equipped with wireless data transmission, a biocompatible casing, low-energy electronics, and a compact battery, it enables continuous, noninvasive monitoring of internal gut conditions, supporting early diagnosis of inflammation, oxidative stress, and microbiome imbalances.
Major companies operating in the digestible sensor market are Medtronic plc, Koninklijke Philips N.V., Otsuka Pharmaceutical Co Ltd, Olympus Corporation, Sencure B.V., Millar Inc., Check-Cap Ltd, Proteus Digital Health Inc., CapsoVision Inc., Atmo Biosciences, IntroMedic Co Ltd, BodyCAP S.A.S., Capsule Technologies Inc., etectRx Inc., Motus GI Inc., SmartPill Corporation, JINSHAN Science & Technology Group Co Ltd, MC10, Medtronic GI Solutions, Proteus GI Technologies
North America was the largest region in the digestible sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digestible sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digestible sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The digestible sensor market consists of sales of ingestion event marker (IEM), electronic pills, and ingestible thermometers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digestible Sensor Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses digestible sensor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for digestible sensor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digestible sensor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.